Citation: | SHAO Hua, SONG Yifan, HE Jie, HU Linlin. Pharmacokinetics and drug concentration monitoring of high-dose tigecycline in patients with septic shock[J]. Journal of China Pharmaceutical University, 2017, 48(6): 721-726. DOI: 10.11665/j.issn.1000-5048.20170614 |
[1] |
Meagher AK, Passarell JA, Cirincione BB, et al. Exposure-response analyses of tigecycline efficacy in patients with complicated skin and skin-structure infections[J].Antimicrob Agents Chemother,2007,51(6):1939-1945.
|
[2] |
Passarell JA, Meagher AK, Liolios K, et al. Exposure-response analyses of tigecycline efficacy in patients with complicated intra-abdominal infections[J].Antimicrob Agents Chemother,2008,52(1):204-210.
|
[3] |
Rubino CM,Bhavnani SM,Forrest A,et al.Pharmacokinetics-pharmacodynamics of tigecycline in patients with community-acquired pneumonia[J].Antimicrob Agents Chemother,2012,56(1):130-136.
|
[4] |
Shukla A,Zhang R,Orton DJ,et al.Formation of iron complexes from trifluoroacetic acid based liquid chromatography mobile phases as interference ions in liquid chromatography/electrospray ionization mass spectrometric analysis[J].Rapid Commun Mass Spectrom,2011,25(10):1452-1456.
|
[5] |
Shou WZ,Naidong W.Simple means to alleviate sensitivity loss by trifluoroacetic acid(TFA)mobile phases in the hydrophilic interaction chromatography-electrospray tandem mass spectrometric(HILIC-ESI/MS/MS)bioanalysis of basic compounds[J].Chromatogr B Analyt Technol Biomed Life Sci,2005,825(2):186-192.
|
[6] |
Chen Q,Tung EC,Ciccotto SL,et al.Effect of the anticoagulant ethylenediamine tetra-acetic acid(EDTA)on the estimation of pharmacokinetic parameters:a case study with tigecycline and ciprofloxacin[J].Xenobiotica,2008,38(1):76-86.
|
[7] |
Xie J,Wang T,Wang X,et al.Quantitative analysis and pharmacokinetics study of tigecycline in human serum using a validated sensitive liquid chromatography with tandem mass spectrometry method[J].J Sep Sci,2014,37(12):1396.
|
[8] |
Zhang H.PK/PD study of antimicrobial agents in patients with severe sepsis[D].Nanjing:Nanjing University of Chinese Medicine,2016.
|
[9] |
Hu LL,Guo N,Zhang XL,et al.The UPLC-MS/MS method of daptomycin and its pharmacokinetic evaluation in patients with septic shock during continuous venovenous hemofiltration[J].J China Pharm Univ(中国药科大学学报),2015,46(6):700-706.
|
[10] |
Varghese JM,Roberts JA,Lipman J.Antimicrobial pharmacokinetic and pharmacodynamic issues in the critically ill with severe sepsis and septic shock[J].Crit Care Clin,2011,27(1):19-34.
|
[1] | HU Linlin, GUO Nan, ZHANG Xueli, SHAO Hua. Determination of daptomycin by UPLC-MS/MS and its pharmacokinetic eva-luation in critically ill patients[J]. Journal of China Pharmaceutical University, 2015, 46(6): 700-706. DOI: 10.11665/j.issn.1000-5048.20150611 |
[2] | HAO Kun, YU Dan, WANG Guangji. Pharmacokinetic translational research from bench to bedside[J]. Journal of China Pharmaceutical University, 2015, 46(1): 50-57. DOI: 10.11665/j.issn.1000-5048.20150105 |
[3] | LIANG Yan, XING Rong, LIU Jiali, MAO Yong, FU Hanxu, XIE Lin, WANG Guangji. Advances of novel technologies and theories in pharmacokinetic research[J]. Journal of China Pharmaceutical University, 2014, 45(6): 607-616. DOI: 10.11665/j.issn.1000-5048.20140601 |
[4] | Application of pharmacometrics in drug development and therapeutic drug monitoring[J]. Journal of China Pharmaceutical University, 2010, 41(1): 91-96. |
[5] | Pharmacokinetics Studies of 99mTc-BM[J]. Journal of China Pharmaceutical University, 2004, (3): 57-59. |
[6] | Pharmacokinetics of 0325k1-1 in Dogs[J]. Journal of China Pharmaceutical University, 2003, (4): 79-81. |
[7] | Pharmacokinetics of Aceclofenac in Rats[J]. Journal of China Pharmaceutical University, 1998, (4): 68-70. |
[8] | Pharmacokinetics and Pharmacodynamics of Sophocarpine and Oxysophocarpine[J]. Journal of China Pharmaceutical University, 1992, (3): 161-164. |
[9] | PHARMACOKINETICS OF MATRINR IN RABBITS[J]. Journal of China Pharmaceutical University, 1986, (4): 309-311. |
[10] | PHARMACOKINETICS OF OCTANOYLPRIMAQUINE IN RABBITS[J]. Journal of China Pharmaceutical University, 1986, (2): 125-128. |